Together with our experts, we shared some insights on how you can build safe and reliable AI for health care and share some interesting real-world use cases.
Our experts:
Bardia M. Zanganeh, Senior Business Development Manager
Gabriel Krummenacher, Principal Data Scientist
Together with our experts we’ve discussed about how a new class of digital health products are enhancing traditional chemical or biological approaches from the pharmaceutical industry, with the potential in some cases to even become suitable alternatives.
With the advent of Coronavirus, in early March, Wolfgang Emmerich, the CEO of Zühlke Engineering UK was invited to meet the CEO of DHSC Test & Trace. DHSC sought technical oversight on a mobile app using Bluetooth to detect contact events. The goal was to design and develop a feature rich, medical grade contact tracing app, which could scale to millions of users, be accurate, and ensure data privacy in twelve weeks.
In this webcast, you will learn how Zühlke helped in:
As a start-up, chances are you are currently or in the foreseeable future raising money. You certainly want to make sure to present yourself and your company in the best light in front of the investors. To achieve this, it would clearly be advantageous to know how investors assess start-ups, what factors influence their decision making and what motivates them to move ahead with their investment.
We invite you to learn about the perspective an investor has on the due diligence process. Apart from the process itself, we address
This webcast is intended to provide insurance business leaders with a perspective on:
On this panel discussion, we took in questions from the audience and discussed topics around:
Collaborating with big corporates is a good way for startups to increase their chance for a long term success. Especially in industries with high market-entrance barriers, like Pharma or MedTech, corporates can bring in essential capital, experience and industrialization-power. Nevertheless, only a fraction of all startups collaborate with corporates and half of them (according to Boston Consulting) are unsatisfied with their partnership.
In this webinar we want to talk about expectations, cultural differences, collaboration and the relationship between startups and corporates from a neutral point of view.
In this Webcast we will show how AI projects can be executed in a regulated setting. We will talk about the specifics of a medical Machine Learning project and how the Data Science Process needs to be adapted at each phase to satisfy regulatory requirements.
We will cover the following topics for AI in health:
Speakers:
